Abstract
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia that results from abnormal secretion of insulin, inappropriate action of insulin or both. The aim of this study is to determine the effects of exenatide and sitagliptin treatment on the expression of insulin (INS-1), insulin receptor (INSR) and insulin receptor substrate (IRS-1) genes. In this study streptozotocin-induced diabetic rats were treated with sitagliptin (10 mg/kg) and exenatide (0.1 µg/kg) for 15 days. We measured INS-1, INSR and IRS-1 gene expression levels and examined the histology of pancreatic tissues in all groups. Exenatide and sitagliptin treatment increased gene expression levels of INS-1, INSR and IRS-1.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1068162023030275/MediaObjects/11171_2023_8718_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1068162023030275/MediaObjects/11171_2023_8718_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1068162023030275/MediaObjects/11171_2023_8718_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS1068162023030275/MediaObjects/11171_2023_8718_Fig4_HTML.png)
Similar content being viewed by others
REFERENCES
Cernea, S. and Dobreanu, M., Biochem. Med., 2021, vol. 23, pp. 266–280. https://doi.org/10.11613/bm.2013.033
Skyler, J.S., Bakris, G.L., Bonifacio, E., Darsow, T., Eckel, R.H., Groop, L., Groop, P.H., Handelsman, Y., Insel, R.A., Mathieu, C., McElvaine, A.T, Palmer J.P., Pugliese, A., Schatz, D.A., Sosenko, J.M., Wilding, J.P., and Ratner, R.E., Diabetes, 2017, vol. 66, pp. 241–255. https://doi.org/10.2337/db16-0806
Schofield, J.D., Liu, Y., Rao-Balakrishna, P., Malik, R.A., and Soran, H., Diabetes Ther., 2016, vol. 7, pp. 203–219. https://doi.org/10.1007/s13300-016-0167-x
Tan, G.H., Ann. Glob. Health, 2015, vol. 81, pp. 863–869. https://doi.org/10.1016/j.aogh.2015.10.004
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A.A., Ogurtsova, K., Shaw, J.E., Bright, D., and Williams, R., G Diabetes Res. Clin. Pract., 2019, vol. 157, p. 107843. https://doi.org/10.1016/j.diabres.2019.107843
Rowley, W.R., Bezold, C., Arikan, Y., Byrne, E., and Krohe, S., Popul. Health Manage., 2017, vol. 20, pp. 6–12. https://doi.org/10.1089/pop.2015.0181
Kalwat, M.A. and Cobb, M.H., Pharmacol. Ther., 2017, vol. 179, pp. 17–30. https://doi.org/10.1016/j.pharmthera.2017.05.003
Chakraborty, C., Doss, C.G., Bandyopadhyay, S., and Agoramoorthy, G., Rev. RNA, 2014, vol. 5, pp. 697–712. https://doi.org/10.1002/wrna.1240
Kido, Y. Nakae, J., and Accili, D., J. Clin. Endocrinol. Metab., 2001, vol. 86, pp. 972–979. https://doi.org/10.1210/jcem.86.3.7306
Ho, J., Leung, A.K., and Rabi, D., Recent Pat. Endocr. Metab. Immune Drug Discov., 2011, vol. 5, pp. 66–73. https://doi.org/10.2174/187221411794351879
Fonseca, V.A., Clin. Ther., 2014, vol. 36, pp. 477–484. https://doi.org/10.1016/j.clinthera.2014.01.018
Todd, J.F. and Bloom, S.R., Diabet. Med., 2007, vol. 24, pp. 223–232. https://doi.org/10.1111/j.1464-5491.2006.02071.x
Sharma, D., Verma, S., Vaidya, S., Kalia, K., and Tiwari, V., Biomed. Pharmacother., 2018, vol. 108, pp. 952–962. https://doi.org/10.1016/j.biopha.2018.08.088
DeGeeter, M. and Williamson, B., J. Pharm. Pract., 2016, vol. 29, pp. 144–159. https://doi.org/10.1177/0897190014549837
Nadkarni, P., Chepurny, O.G., and Holz, G.G., Prog. Mol. Biol. Transl. Sci., 2014, vol. 121, pp. 23–65. https://doi.org/10.1016/B978-0-12-800101-1.00002-8
El-Kordy, E.A., and Alshahrani, A.M., J. Microsc. Ultrastruct., 2015, vol. 3, pp. 108–119. https://doi.org/10.1016/j.jmau.2015.03.005
Salama, A., Asaad, G.F., and Shaheen, A., Res. Pharm. Sci., 2022, vol. 17, pp. 1–11, https://doi.org/10.4103/1735-5362.329921
Yildirim, M., Degirmenci, U., Akkapulu, M., Comelekoglu, U., Balli, E., Metin Ozcan, T., Berkoz, M., Yalin, A.E., and Yalin, S., J. Basic Clin. Physiol. Pharmacol., 2020. https://doi.org/10.1515/jbcpp-2020-0058
Tan, S.Y., Mei Wong, J.L., Sim, Y.J., Wong, S.S., Mohamed Elhassan, S.A., Tan, S.H., Ling Lim, G.P., Rong Tay, N.W., Annan, N.C., Bhattamisra, S.K., and Candasamy M., Diabetes Metab. Syndr., 2019, vol. 13, pp. 364–372. https://doi.org/10.1016/j.dsx.2018.10.008
Plosker, G.L., Drugs, 2014, vol. 74, pp. 223–242. https://doi.org/10.1007/s40265-013-0169-1
Atmodjo, W.L., Larasati, Y.O., Jo, J., Nufika, R., Naomi, S., and Winoto, I., In Vivo, 2021,vol. 35, pp. 291–297. https://doi.org/10.21873/invivo.12258
Gumuslu, E., Mutlu, O., Celikyurt, I.K., Ulak, G., Akar, F., Erden, F., and Ertan, M., Fundam. Clin. Pharmacol., 2016, vol. 30, pp. 376–384. https://doi.org/10.1111/fcp.12192
Gumuslu, E., Cine, N., Ertan, M., Mutlu, O., Komsuoglu Celikyurt, I., and Ulak, G., Fundam. Clin. Pharmacol., 2018, vol. 32, pp. 174–180. https://doi.org/10.1111/fcp.12329
Saad, M.I., Kamel, M.A., and Hanafi, M.Y., Biochem. Res. Int., 2015, vol. 2015, p. 138134. https://doi.org/10.1155/2015/138134
Zhao, Q.,Yang, Y., Hu, J., Shan, Z., Wu, Y., and Lei, L., Arch. Med. Sci., 2016, vol. 12, pp. 199–207. https://doi.org/10.5114/aoms.2016.57596
Abdelmageed, M.E., Shehatou, G.S., Abdelsalam, R.A., Suddek, G.M., and Salem, H.A., Naunyn Schmiedebergs Arch. Pharmacol., 2019, vol. 392, pp. 243–258. https://doi.org/10.1007/s00210-018-1583-1584
Vargas Guerrero, B., Garcia Lopez, P.M., Gonzalez Santiago, A.E., Dominguez Rosales, J.A., and Gurrola Diaz, C.M., Biol. Res., 2013, vol. 46, pp. 281–288. https://doi.org/10.4067/S0716-97602013000300009
Abraham, P.M., Kuruvilla, K.P., Mathew, J., Malat, A., Joy, S., and Paulose, C.S., J. Biomed. Sci., 2010, vol. 17, pp. 78. https://doi.org/10.1186/1423-0127-17-78
Shehata, N.I., Abo Zeid, S.M., Abd El Aziz, S.A., and Abdelgawad, H.M., J. Food Biochem., 2022, vol. 46, p. e14086. https://doi.org/10.1111/jfbc.14086
Wang, G., Zhao, Z., Ren, B., Yu, W., Zhang, X., Liu, J., Wang, L., Si, D., and Yang, M., Mol. Med. Rep., 2022, vol. 25. https://doi.org/10.3892/mmr.2022.12627
Xie, K.J. Huang, L. Qu, X.H., Li, X., Wang, S.J, and Xiao, M., Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2019, vol. 35, pp. 60–64. https://doi.org/10.12047/j.cjap.5589.2019.015
Li, Y., Zheng, J., Shen, Y., Li, W., Liu, M., Wang, J., Zhu, S., and Wu, M., Med. Sci Monit., 2018, vol. 24, pp. 3293–3300. https://doi.org/10.12659/MSM.907227
Funding
This study was supported by funding from the Mersin University Scientific Research Projects (Project no. 2017-2-AP3-2532), Mersin, Turkey.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflicts of interest.
Statement on the welfare of animals. Ethics Committee Certificate of Approval was obtained from Mersin University Local Ethics Committee for Animal Experiments (HADYEK).
Rights and permissions
About this article
Cite this article
Yildirim, M., Mistik, O.A., Yalin, A.E. et al. The Effect of Sitagliptin and Exenatide on Insulin, Insulin Receptor and Insulin Receptor Substrate Gene Expression in Diabetic Rats. Russ J Bioorg Chem 49, 610–615 (2023). https://doi.org/10.1134/S1068162023030275
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162023030275